BackNovo Nordisk A/S Class B Overview
Novo Nordisk A/S Class B

Novo Nordisk A/S Class B Return on Equity

Return on Equity (ROE) for NONOF.

Get informed when a big investor buys or sells

+ Follow

ROE

60.03%

Return on Equity

60.03%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

Average ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading